Validation of the EKFC equation for glomerular filtration rate estimation and comparison with the Asian-modified CKD-EPI equation in Chinese chronic kidney disease patients in an external study

The aim of this study is to determine whether new European Kidney Function Consortium (EKFC) equation is more applicable than Asian-modified CKD-EPI equation in clinical practice, having a higher accuracy in estimating GFR in our external CKD population. We calculated estimated GFR EKFC and GFR CKD-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Renal failure 2023-12, Vol.45 (1), p.2150217-2150217
Hauptverfasser: Zhao, Li, Li, Huan-li, Liu, Hui-jing, Ma, Jin, Liu, Wei, Huang, Jian-min, Wei, Ling-ge, Xie, Peng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The aim of this study is to determine whether new European Kidney Function Consortium (EKFC) equation is more applicable than Asian-modified CKD-EPI equation in clinical practice, having a higher accuracy in estimating GFR in our external CKD population. We calculated estimated GFR EKFC and GFR CKD-EPI independently using the EKFC and Asian-modified CKD-EPI formulas, respectively. The clinical diagnostic performance of the two equations was assessed and compared by median bias, precision, accuracy (P 30 ) and so on, using 99m Tc-DTPA dual plasma sample clearance method as a reference method for GFR measurement (mGFR). The equation that met the following targets was superior: (1) median bias within ± 3 mL/min/1.73 m 2 ; (2) P 30 > 75%; and (3) better precision and 95% limits of agreement in Bland-Altman analysis. Totally, 160 CKD patients were recruited in our external cohort. GFR EKFC was highly related to mGFR, with a regression equation of GFR EKFC =mGFR × 0.87 + 5.27. Compared with the Asian-modified CKD-EPI equation, EKFC equation demonstrated a wider median bias (-1.64 vs. 0.84 mL/min/1.73 m 2 , p 
ISSN:0886-022X
1525-6049
DOI:10.1080/0886022X.2022.2150217